News

We participated in a major study within the CZECANCA project

As part of the Czecanca project , we participated in the scientific study A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer. GHC Genetics has been a long-term active partner of the project and contributes a large amount of laboratory and clinical data.

Opening hours over the Christmas period and at the end of 2024

23.12.2024: 7:00-17:00

24.12-26.12.2024: CLOSED

27.12.2024 7:00-16:00

30.12.2024 7:00-17:00

31.12.2024 7:00-14:00

1.1.2025 CLOSED

Fundraiser for 22 million could yield therapeutic procedure to cure Angelman syndrome

5 years ago, the parents of little Oliver, Lenka and Rado, approached a Czech scientific team within their organization Asgent with one goal - to turn the incurable disease Angelman syndrome into a curable one. And they are succeeding! The research is getting closer and closer to the goal every year. This year, the research team succeeded in creating a proposal for a functional therapeutic procedure. The road to a future cure and the first patients will still be challenging, but the Czech research team is closer than ever. But to reach sick children, they need your help. In order to turn hope into reality, we now need to raise funds to carry out preclinical tests. GHC Genetics has been a proud partner and supporter of Asgent for several years.

Deciphering the chromosome 25 years ago opened the door to treat hereditary diseases

A quarter of a century ago, a team of 100 scientists succeeded in describing the chromosome for the first time. It has helped treat dozens of diseases, but its true potential is still unfolding.

It's like the invention of the wheel. It's like breaking the atom. It's like landing a man on the moon. Twenty-five years ago, that's how the media assessed a scientific discovery made in late 1999. It allowed humanity to enter the twenty-first century with the knowledge of a single human chromosome. It may not seem like much, but this research opened the way for the detection and treatment of hereditary diseases.

Simply put: most of the cases of children for whose treatment money is raised today have gained hope thanks to the description of a chromosome that has made possible genetic treatments for diseases that science had not known how to deal with until then.